Masimo Income Statement
MASI / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Masimo reported $1.5B in revenue and $152M in net loss for FY2025. Revenue has grown at a 11.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $2.0B | $299.0M | $1.1B | $790.2M | $712.9M | $790.2M | $586.6M | $547.2M | $493.2M | $439.0M | $493.2M | $349.1M |
| Cost of Revenue | $581.7M | $600.9M | $509.9M | $977.0M | $430.8M | $400.7M | $268.2M | $234.6M | $268.2M | $195.9M | $188.4M | $167.0M | $144.9M | $167.0M | $100.3M |
| Gross Profit | $945.2M | $794.3M | $765.6M | $1.1B | $808.4M | $743.0M | $522.0M | $478.3M | $522.0M | $390.8M | $358.8M | $326.3M | $294.1M | $326.3M | $248.8M |
| SG&A Expense | $506.0M | $548.6M | $451.3M | $657.4M | $395.4M | $369.0M | $273.0M | $254.7M | $273.0M | $241.0M | $215.5M | $193.9M | $169.2M | $193.9M | $134.6M |
| R&D Expense | $126.4M | $182.2M | $130.5M | $191.4M | $137.2M | $118.7M | $65.2M | $57.7M | $65.2M | $56.6M | $55.6M | $47.1M | $38.4M | $47.1M | $31.7M |
| Operating Income | $310.0M | $63.0M | $166.0M | $210.0M | $275.8M | $255.8M | $183.8M | $435.9M | $183.8M | $103.5M | $79.7M | $85.2M | $86.5M | $85.2M | $82.2M |
| Interest Expense | - | - | $50.3M | $25.7M | $300.0K | $300.0K | $678.0K | $3.3M | $678.0K | $600.0K | $100.0K | $100.0K | - | $100.0K | - |
| Income Tax | $64.9M | $5.6M | $5.3M | $49.9M | $44.8M | $23.4M | $61.0M | $122.4M | $61.0M | $27.7M | $20.0M | $21.9M | $22.5M | $21.9M | $28.2M |
| Net Income | -$151.5M | -$304.9M | $81.5M | $143.5M | $229.6M | $64.5M | $49.3M | $311.1M | $124.8M | $72.5M | $58.4M | $62.3M | $63.7M | $62.3M | $53.2M |
| EPS (Basic) | $1.54 | $2.68 | $4.16 | $4.39 | $3.67 | $3.70 | $2.42 | $6.28 | $1.62 | $1.33 | $1.03 | $1.08 | $1.07 | $1.25 | $0.92 |
| EPS (Diluted) | $1.51 | $2.60 | $3.98 | $4.14 | $3.44 | $3.45 | $2.23 | $5.85 | $1.55 | $1.30 | $1.02 | $1.07 | $1.05 | $1.21 | $0.88 |
| Shares Outstanding | 53.6M | 52.8M | 52.5M | 55.3M | 55.3M | 53.7M | 53.1M | 51.6M | 50.2M | 49.9M | 52.6M | 56.6M | 57.3M | 58.2M | 59.5M |
| Gross Margin | 61.9% | 56.9% | 60.0% | 52.0% | 270.3% | 65.0% | 66.1% | 67.1% | 66.1% | 66.6% | 65.6% | 66.1% | 67.0% | 66.1% | 71.3% |
| Operating Margin | 20.3% | 4.5% | 13.0% | 10.3% | 92.2% | 22.4% | 23.3% | 61.2% | 23.3% | 17.6% | 14.6% | 17.3% | 19.7% | 17.3% | 23.5% |
| Profit Margin | -9.9% | -21.9% | 6.4% | 7.0% | 76.8% | 5.6% | 6.2% | 43.6% | 15.8% | 12.4% | 10.7% | 12.6% | 14.5% | 12.6% | 15.3% |